Home » Latest Research Trends » Latest Research Trends in BioScience (02 September, 2026)

Latest Research Trends in BioScience (02 September, 2026)

A cell fate specification and transition mechanism for human foveolar cone subtype patterning

Journal: PNAS

Author: K.A. Hussey et al., USA

Researchers uncover how retinoic acid and thyroid hormone signaling shape cone fate, revealing mechanisms that build the foveola’s specialized architecture and inform retinal organoid engineering.

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial

Journal: Nature Medicines

Author: Fredrik N. Albach, Marie C. Rehm, Marie Luise Hütter-Krönke, Thanh Hang Le, Julia M. Giezen et al., Germany

Early clinical data suggest CD19 CAR T cells can safely deplete B cells, reduce autoantibodies and improve disease activity in treatment-refractory rheumatoid arthritis.

DHODH is a synthetic lethal target in PIK3CA-mutant colorectal cancer

Journal: Cell Reports

Author: Jun Liang, Xi Liu, Ziyun Ni et al., China

Targeting DHODH disrupts PI3K-AKT signaling and suppresses tumor growth, revealing a metabolic vulnerability that could enable precision treatment of PIK3CA-mutant colorectal cancer.

HDAC-driven autophagy repression aids macrophage immune evasion by K. pneumoniae strains displaying classical, MDR, and hypervirulent phenotypes

Journal: iScience

Author: Abhinand K, Sony S, Anil A et al., India

Klebsiella pneumoniae exploits HDAC-mediated autophagy suppression to evade macrophage defenses, while HDAC inhibition restores bacterial clearance and immune responses.

Subscribe
to the latest updates in the newsletter

Related Solutions

  • Disease Modeling
  • Oncology
  • Organoid
  • Cosmetics
  • OECD TG
  • Zebrafish
  • Bioinfomatics
  • Live&3D Imaging
  • Molecular biology
  • Spatial Biology
Technical Service

Next Articles

Thank you for your submission.

Our team has received your request and will get back to you shortly with tailored workflows and relevant case studies for your ADC efficacy and toxicity evaluation needs.
If you do not receive our confirmation email, kindly check your spam or junk folder.

Thank you for your interest

You can now download the file.

Connect with Us